£18.5M
Pureland Global Venture led the Series B financing round to support the commercialisation of upright treatment technology.

Leo Cancer Care builds upright radiotherapy systems to improve cancer treatment.
Leo Cancer Care develops upright radiotherapy solutions that improve clinical effectiveness and patient experience. The firm builds gantryless systems designed to make particle and proton therapy more accessible.

Stephen Towe
CEO
Stephen serves as chief executive officer at Leo Cancer Care and holds a board position at Asto CT. He previously held product and engineering roles at Leo Cancer Care and Elekta.
LinkedInFiona Redford
Marketing Manager
Pureland Global Venture led the Series B financing round to support the commercialisation of upright treatment technology.